These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2008035)

  • 21. The Pathogenicity of Anti-β2GP1-IgG Autoantibodies Depends on Fc Glycosylation.
    Fickentscher C; Magorivska I; Janko C; Biermann M; Bilyy R; Nalli C; Tincani A; Medeghini V; Meini A; Nimmerjahn F; Schett G; Muñoz LE; Andreoli L; Herrmann M
    J Immunol Res; 2015; 2015():638129. PubMed ID: 26185769
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advanced glycation endproducts (AGE) on IgG, a target for circulating antibodies in North American Indians with rheumatoid arthritis (RA).
    Newkirk MM; LePage K; Niwa T; Rubin L
    Cell Mol Biol (Noisy-le-grand); 1998 Nov; 44(7):1129-38. PubMed ID: 9846895
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of heat inactivation of serum on aggregation of immunoglobulins.
    Soltis RD; Hasz D; Morris MJ; Wilson ID
    Immunology; 1979 Jan; 36(1):37-45. PubMed ID: 422227
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Altered glycosylation of complexed native IgG molecules is associated with disease activity of systemic lupus erythematosus.
    Sjöwall C; Zapf J; von Löhneysen S; Magorivska I; Biermann M; Janko C; Winkler S; Bilyy R; Schett G; Herrmann M; Muñoz LE
    Lupus; 2015 May; 24(6):569-81. PubMed ID: 25389233
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Presence of complement-fixing anti-endothelial cell antibodies in systemic lupus erythematosus.
    Cines DB; Lyss AP; Reeber M; Bina M; DeHoratius RJ
    J Clin Invest; 1984 Mar; 73(3):611-25. PubMed ID: 6368583
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Complement fixation activity of immunoglobulin G in ethylene glycol solutions].
    Tétin SIu; Efetov KA; Troitskiĭ GV; Kozlov LV; Zinchenko AA
    Bioorg Khim; 1985 Aug; 11(8):1068-73. PubMed ID: 4062991
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complement fixation by solid phase immune complexes. Reduced capacity in SLE sera.
    Baatrup G; Jonsson H; Sjöholm A; Sturfelt G; Svehag SE
    J Clin Lab Immunol; 1988 Jun; 26(2):73-9. PubMed ID: 3264027
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Binding of immunoglobulin G aggregates and immune complexes in human sera to Staphylococci containing protein A.
    McDougal JS; Redecha PB; Inman RD; Christian CL
    J Clin Invest; 1979 Apr; 63(4):627-36. PubMed ID: 438327
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-enzymic glycation of individual plasma proteins in normoglycemic and hyperglycemic patients.
    Austin GE; Mullins RH; Morin LG
    Clin Chem; 1987 Dec; 33(12):2220-4. PubMed ID: 3690840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preferential recognition of Amadori-rich lysine residues by serum antibodies in diabetes mellitus: role of protein glycation in the disease process.
    Ansari NA; Moinuddin ; Alam K; Ali A
    Hum Immunol; 2009 Jun; 70(6):417-24. PubMed ID: 19332092
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunoglobulin G subclass distribution of bullous pemphigoid autoantibodies and complement fixation studies.
    Al-Karawi KS
    Saudi Med J; 2002 Dec; 23(12):1492-5. PubMed ID: 12518199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glycation increases the vascular clearance rate of IgG in mice.
    Kennedy DM; Skillen AW; Self CH
    Clin Exp Immunol; 1993 Dec; 94(3):447-51. PubMed ID: 8252805
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complement fixation by rheumatoid factor.
    Tanimoto K; Cooper NR; Johnson JS; Vaughan JH
    J Clin Invest; 1975 Mar; 55(3):437-45. PubMed ID: 1078825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A study of complement fixation by rheumatoid factor using a haemolytic assay system.
    Taylor-Upsahl MM; Johnson PM; Mellbye OJ; Natvig JB
    Clin Exp Immunol; 1977 May; 28(2):204-11. PubMed ID: 872448
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The complement fixing ability of anti-basement membrane zone IgG subclass of herpes gestationis and bullous pemphigoid.
    Suzuki M; Watanabe C; Yaoita H
    Acta Derm Venereol; 1989; 69(1):6-11. PubMed ID: 2563610
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathogenetic role of mesangial immune deposits.
    Batsford SR; Takamiya H; Rohrbach R; Vogt A
    Proc Eur Dial Transplant Assoc; 1979; 16():535-41. PubMed ID: 162006
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunological detection of single amino acid substitutions in alkaline phosphatase.
    Cocks GT; Wilson AC
    Science; 1969 Apr; 164(3876):188-9. PubMed ID: 4886674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Staphylococcus aureus opsonization mediated via the classical and alternative complement pathways. A kinetic study using MgEGTA chelated serum and human sera deficient in IgG and complement factors C1s and C2.
    Verbrugh HA; Van Dijk WC; Peters R; Van Der Tol ME; Peterson PK; Verhoef J
    Immunology; 1979 Mar; 36(3):391-7. PubMed ID: 108204
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Breakdown products of C 3 in human synovial fluids.
    Zvaifler NJ
    J Clin Invest; 1969 Aug; 48(8):1532-42. PubMed ID: 4183680
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of natural IgM binding and complement activation by natural IgG antibodies: a role for IgG anti-Gal alpha1-3Gal antibodies.
    Yu PB; Holzknecht ZE; Bruno D; Parker W; Platt JL
    J Immunol; 1996 Dec; 157(11):5163-8. PubMed ID: 8943428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.